390 related articles for article (PubMed ID: 2407783)
1. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line.
Stoeck M; Miescher S; MacDonald HR; Von Fliedner V
J Cell Physiol; 1989 Oct; 141(1):65-73. PubMed ID: 2789227
[TBL] [Abstract][Full Text] [Related]
3. Effect of transforming growth factor-beta on early and late activation events in human T cells.
Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
[TBL] [Abstract][Full Text] [Related]
4. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
5. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
6. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
Cleveland JL; Rapp UR; Farrar WL
J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
[TBL] [Abstract][Full Text] [Related]
7. Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).
Kupper T; Flood P; Coleman D; Horowitz M
J Immunol; 1987 Jun; 138(12):4288-92. PubMed ID: 2953804
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
[TBL] [Abstract][Full Text] [Related]
10. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
Lee HM; Rich S
J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression.
Weller M; Constam DB; Malipiero U; Fontana A
Eur J Immunol; 1994 Jun; 24(6):1293-300. PubMed ID: 8206089
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
Kanatani Y; Kasukabe T; Okabe-Kado J; Hayashi S; Yamamoto-Yamaguchi Y; Motoyoshi K; Nagata N; Honma Y
Cell Growth Differ; 1996 Feb; 7(2):187-96. PubMed ID: 8822202
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.
Ortaldo JR; Mason AT; O'Shea JJ; Smyth MJ; Falk LA; Kennedy IC; Longo DL; Ruscetti FW
J Immunol; 1991 Jun; 146(11):3791-8. PubMed ID: 1851793
[TBL] [Abstract][Full Text] [Related]
14. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC
J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells.
Mulder KM; Zhong Q; Choi HG; Humphrey LE; Brattain MG
Cancer Res; 1990 Dec; 50(23):7581-6. PubMed ID: 1701348
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors.
Siepl C; Malipiero UV; Fontana A
J Immunol; 1991 May; 146(9):3063-7. PubMed ID: 1849940
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.
Wahl SM; Hunt DA; Wong HL; Dougherty S; McCartney-Francis N; Wahl LM; Ellingsworth L; Schmidt JA; Hall G; Roberts AB
J Immunol; 1988 May; 140(9):3026-32. PubMed ID: 3129508
[TBL] [Abstract][Full Text] [Related]
18. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
19. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
[TBL] [Abstract][Full Text] [Related]
20. IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes.
Casey LS; Lichtman AH; Boothby M
J Immunol; 1992 Jun; 148(11):3418-26. PubMed ID: 1588041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]